185 related articles for article (PubMed ID: 24418286)
1. Contrast-enhanced CT and diffusion-weighted MR imaging: performance as a prognostic factor in patients with pancreatic ductal adenocarcinoma.
Fukukura Y; Takumi K; Higashi M; Shinchi H; Kamimura K; Yoneyama T; Tateyama A
Eur J Radiol; 2014 Apr; 83(4):612-9. PubMed ID: 24418286
[TBL] [Abstract][Full Text] [Related]
2. Prognostic relevance of apparent diffusion coefficient obtained by diffusion-weighted MRI in pancreatic cancer.
Kurosawa J; Tawada K; Mikata R; Ishihara T; Tsuyuguchi T; Saito M; Shimofusa R; Yoshitomi H; Ohtsuka M; Miyazaki M; Yokosuka O
J Magn Reson Imaging; 2015 Dec; 42(6):1532-7. PubMed ID: 25946483
[TBL] [Abstract][Full Text] [Related]
3. Added value of diffusion-weighted imaging to MR cholangiopancreatography with unenhanced mr imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas.
Kang KM; Lee JM; Shin CI; Baek JH; Kim SH; Yoon JH; Han JK; Choi BI
J Magn Reson Imaging; 2013 Sep; 38(3):555-63. PubMed ID: 23390008
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced and diffusion weighted imaging.
Guo C; Chen X; Wang Z; Xiao W; Wang Q; Sun K; Zhuge X
Oncotarget; 2017 Jun; 8(26):42962-42973. PubMed ID: 28487490
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic adenocarcinoma: variability of diffusion-weighted MR imaging findings.
Fukukura Y; Takumi K; Kamimura K; Shindo T; Kumagae Y; Tateyama A; Nakajo M
Radiology; 2012 Jun; 263(3):732-40. PubMed ID: 22623694
[TBL] [Abstract][Full Text] [Related]
6. Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations.
Kim JH; Park SH; Yu ES; Kim MH; Kim J; Byun JH; Lee SS; Hwang HJ; Hwang JY; Lee SS; Lee MG
Radiology; 2010 Oct; 257(1):87-96. PubMed ID: 20697118
[TBL] [Abstract][Full Text] [Related]
7. Imaging features of small (≤ 3 cm) pancreatic solid tumors on gadoxetic-acid-enhanced MR imaging and diffusion-weighted imaging: an initial experience.
Jang KM; Kim SH; Kim YK; Park MJ; Lee MH; Hwang J; Rhim H
Magn Reson Imaging; 2012 Sep; 30(7):916-25. PubMed ID: 22495239
[TBL] [Abstract][Full Text] [Related]
8. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
Distler M; Pilarsky E; Kersting S; Grützmann R
Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
[TBL] [Abstract][Full Text] [Related]
9. Prediction of vascular involvement and resectability by multidetector-row CT versus MR imaging with MR angiography in patients who underwent surgery for resection of pancreatic ductal adenocarcinoma.
Lee JK; Kim AY; Kim PN; Lee MG; Ha HK
Eur J Radiol; 2010 Feb; 73(2):310-6. PubMed ID: 19070981
[TBL] [Abstract][Full Text] [Related]
10. Comparison of F-18-FDG PET/CT findings between pancreatic solid pseudopapillary tumor and pancreatic ductal adenocarcinoma.
Kim YI; Kim SK; Paeng JC; Lee HY
Eur J Radiol; 2014 Jan; 83(1):231-5. PubMed ID: 24290142
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of ADC measurements among solid pancreatic masses by respiratory-triggered diffusion-weighted MR imaging with inversion-recovery fat-suppression technique at 3.0T.
Yao XZ; Yun H; Zeng MS; Wang H; Sun F; Rao SX; Ji Y
Magn Reson Imaging; 2013 May; 31(4):524-8. PubMed ID: 23200681
[TBL] [Abstract][Full Text] [Related]
12. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.
Kamel IR; Bluemke DA; Eng J; Liapi E; Messersmith W; Reyes DK; Geschwind JF
J Vasc Interv Radiol; 2006 Mar; 17(3):505-12. PubMed ID: 16567675
[TBL] [Abstract][Full Text] [Related]
13. Visual enhancement pattern during the delayed phase of enhanced CT as an independent prognostic factor in stage IV pancreatic ductal adenocarcinoma.
Fukukura Y; Kumagae Y; Higashi R; Hakamada H; Nagano H; Hidaka S; Kamimura K; Maemura K; Arima S; Yoshiura T
Pancreatology; 2020 Sep; 20(6):1155-1163. PubMed ID: 32800574
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted magnetic resonance imaging of pancreatic adenocarcinomas: association with histopathology and tumor grade.
Wang Y; Chen ZE; Nikolaidis P; McCarthy RJ; Merrick L; Sternick LA; Horowitz JM; Yaghmai V; Miller FH
J Magn Reson Imaging; 2011 Jan; 33(1):136-42. PubMed ID: 21182131
[TBL] [Abstract][Full Text] [Related]
15. Missed pancreatic ductal adenocarcinoma: Assessment of early imaging findings on prediagnostic magnetic resonance imaging.
Jang KM; Kim SH; Kim YK; Song KD; Lee SJ; Choi D
Eur J Radiol; 2015 Aug; 84(8):1473-1479. PubMed ID: 26032128
[TBL] [Abstract][Full Text] [Related]
16. The effect of gadolinium chelate contrast agent on diffusion-weighted imaging of pancreatic ductal adenocarcinoma.
Liu K; Peng W; Zhou Z
Acta Radiol; 2013 May; 54(4):364-8. PubMed ID: 23386737
[TBL] [Abstract][Full Text] [Related]
17. PET/MRI in pancreatic and periampullary cancer: correlating diffusion-weighted imaging, MR spectroscopy and glucose metabolic activity with clinical stage and prognosis.
Chen BB; Tien YW; Chang MC; Cheng MF; Chang YT; Wu CH; Chen XJ; Kuo TC; Yang SH; Shih IL; Lai HS; Shih TT
Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1753-64. PubMed ID: 26993317
[TBL] [Abstract][Full Text] [Related]
18. Mucin-producing tumor of the pancreas: diagnostic value of diffusion-weighted echo-planar MR imaging.
Yamashita Y; Namimoto T; Mitsuzaki K; Urata J; Tsuchigame T; Takahashi M; Ogawa M
Radiology; 1998 Sep; 208(3):605-9. PubMed ID: 9722835
[TBL] [Abstract][Full Text] [Related]
19. Non-small cell lung cancer: detection of early response to chemotherapy by using contrast-enhanced dynamic and diffusion-weighted MR imaging.
Yabuuchi H; Hatakenaka M; Takayama K; Matsuo Y; Sunami S; Kamitani T; Jinnouchi M; Sakai S; Nakanishi Y; Honda H
Radiology; 2011 Nov; 261(2):598-604. PubMed ID: 21852569
[TBL] [Abstract][Full Text] [Related]
20. Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging.
Murakami R; Sugahara T; Nakamura H; Hirai T; Kitajima M; Hayashida Y; Baba Y; Oya N; Kuratsu J; Yamashita Y
Radiology; 2007 May; 243(2):493-9. PubMed ID: 17356177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
